Baker McKenzie advised EQT Life Sciences on the deal. EQT Life Sciences successfully closed a EUR 128 million (USD 138.8 million) Series B2 financing of Tubulis GmbH....
Tubulis GmbH’s Series B2 Financing
Amolyt Pharma’s EUR 138 Million Fund Raising
Goodwin advised Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day advised Amolyt Pharma. McDermott Will & Emery advised Andera Partners, Novo Holdings...